Chemistry's Robert Salomon discusses potential asthma treatment discovery
New discovery could change how asthma is treated, scientists say
U.S. News & World Report: Robert Salomon, the Charles Frederic Mabery Professor of Research in Chemistry, identified “pseudo leukotrienes” as potential key drivers of asthma inflammation. Salomon said these molecules may be more important than traditional leukotrienes, opening the door to treatments that target free radical processes rather than simply blocking inflammation receptors.
